Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Inaccurate MDS Assessment of Medication Administration

Pasadena, California Survey Completed on 05-05-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure an accurate assessment of a resident's medication on the Minimum Data Set (MDS) as required by facility policy. A resident was admitted with diagnoses including unspecified dislocation of the left hip, abnormalities of gait and mobility, and hyperlipidemia. The resident was prescribed Ozempic, a weekly injection for weight loss, and not insulin. However, the MDS assessment incorrectly documented that the resident received insulin for 7 days during the look-back period and also inaccurately recorded the frequency of Ozempic administration as daily injections for 7 days, rather than the correct weekly administration. Interviews with the resident, the MDS nurse, and the DON confirmed that the resident was not receiving insulin and that Ozempic was not classified as insulin. The MDS nurse acknowledged the errors in both the classification and frequency of the medication on the MDS. Facility policy required all persons completing any portion of the MDS to attest to the accuracy of the information, and documentation was to be objective, complete, and accurate. These requirements were not met in this instance.

An unhandled error has occurred. Reload 🗙